347819 <common-name>(5e)-5-[(4-chlorophenyl)methylidene]-3-[[4-(4-phenylpiperazine-1-carbonyl)anilino]methyl]-2-sulfanylidene-1,3-thiazolidin-4-one</common-name> <description>(5e)-5-[(4-chlorophenyl)methylidene]-3-[[4-(4-phenylpiperazine-1-carbonyl)anilino]methyl]-2-sulfanylidene-1,3-thiazolidin-4-one is a chemical compound with the formula C28H25ClN4O2S2. With an average molecular weight of 549.10 g/mol, (5e)-5-[(4-chlorophenyl)methylidene]-3-[[4-(4-phenylpiperazine-1-carbonyl)anilino]methyl]-2-sulfanylidene-1,3-thiazolidin-4-one is a heavy molecule.</description> <cas>104183-57-5</cas> <pubchem-id>24842044</pubchem-id> <chemical-formula>C28H25ClN4O2S2</chemical-formula> <weight>549.1</weight> <appearance nil="true"/> <melting-point nil="true"/> <boiling-point nil="true"/> <density nil="true"/> <solubility nil="true"/> <specific-gravity nil="true"/> <flash-point nil="true"/> <vapour-pressure nil="true"/> <route-of-exposure nil="true"/> <target nil="true"/> <mechanism-of-toxicity nil="true"/> <metabolism nil="true"/> <toxicity nil="true"/> <lethaldose nil="true"/> <carcinogenicity nil="true"/> <use-source nil="true"/> <min-risk-level nil="true"/> <health-effects nil="true"/> <symptoms nil="true"/> <treatment nil="true"/> <created-at type="dateTime">2026-08-31T11:38:44Z</created-at> <updated-at type="dateTime">2026-08-31T11:38:44Z</updated-at> <interacting-proteins nil="true"/> <wikipedia nil="true"/> <uniprot-id nil="true"/> <kegg-compound-id nil="true"/> <omim-id nil="true"/> <chebi-id nil="true"/> <biocyc-id nil="true"/> <ctd-id nil="true"/> <stitch-id nil="true"/> <drugbank-id nil="true"/> <pdb-id nil="true"/> <actor-id nil="true"/> <organism nil="true"/> <export type="boolean">true</export> <metabolizing-proteins nil="true"/> <transporting-proteins nil="true"/> <moldb-smiles>C1CN(CCN1C2=CC=CC=C2)C(=O)C3=CC=C(C=C3)NCN4C(=O)C(=CC5=CC=C(C=C5)Cl)SC4=S</moldb-smiles> <moldb-formula>C28H25ClN4O2S2</moldb-formula> <moldb-inchi>InChI=1S/C28H25ClN4O2S2/c29-22-10-6-20(7-11-22)18-25-27(35)33(28(36)37-25)19-30-23-12-8-21(9-13-23)26(34)32-16-14-31(15-17-32)24-4-2-1-3-5-24/h1-13,18,30H,14-17,19H2/b25-18+</moldb-inchi> <moldb-inchikey>FUPKCLIEEFKLDV-XIEYBQDHSA-N</moldb-inchikey> <moldb-average-mass type="decimal" nil="true"/> <moldb-mono-mass type="decimal">548.1107461</moldb-mono-mass> <origin nil="true"/> <state nil="true"/> <logp>6.4</logp> <hmdb-id nil="true"/> <chembl-id nil="true"/> <chemspider-id nil="true"/> <structure-image-file-name nil="true"/> <structure-image-content-type nil="true"/> <structure-image-file-size type="integer" nil="true"/> <structure-image-updated-at type="dateTime" nil="true"/> <biodb-id nil="true"/> <synthesis-reference nil="true"/> <structure-image-caption nil="true"/> <chemdb-id>CHEM343712</chemdb-id> <dsstox-id nil="true"/> <toxcast-id nil="true"/> <stoff-ident-origin nil="true"/> <stoff-ident-id nil="true"/> <susdat-id nil="true"/> <iupac>(5e)-5-[(4-chlorophenyl)methylidene]-3-[[4-(4-phenylpiperazine-1-carbonyl)anilino]methyl]-2-sulfanylidene-1,3-thiazolidin-4-one</iupac> <moldb-polar-surface-area nil="true"/> <moldb-refractivity nil="true"/> <moldb-polarizability nil="true"/> <moldb-rotatable-bond-count nil="true"/> <moldb-acceptor-count nil="true"/> <moldb-donor-count nil="true"/> <moldb-pka-strongest-acidic nil="true"/> <moldb-pka-strongest-basic nil="true"/> <moldb-physiological-charge nil="true"/> <moldb-number-of-rings nil="true"/> <moldb-alogps-logp nil="true"/> <moldb-alogps-logs nil="true"/> <moldb-alogps-solubility nil="true"/> <kingdom>Organic compounds</kingdom> <superklass>Organoheterocyclic compounds</superklass> <klass>Diazinanes</klass> <subklass>Piperazines</subklass> <paper-count type="integer" nil="true"/> <sync-id>CED0298156</sync-id> <structure-inchikey>FUPKCLIEEFKLDV-UHFFFAOYSA-N</structure-inchikey> <structure-fingerprint>40000000020000800040000000000000000000000100000180000000000000404080000020000000000000000004000100000000000000000000084000000000000000400000080000000000000020000010010200000000000000000000000000010080000010000100010000000000020102100000000000000000001000004000020000800000000000000080000000000100000040000000000000000000000000000000000000084000040080000020000000008000008900000000000000000004000000000000400000000010004000040000000200000400000000000040000000000040000000800400000000000000000000004000004008</structure-fingerprint> <structure-pattern-fingerprint>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</structure-pattern-fingerprint> <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAlAAAAKQAAAIABBgBgAAAAAgIGAGAAAAAC AgcAKAAAAAMDBgBgAAAAAgIGAGAAAAACAgcAKAAAAAMDBkAoAAAAAwQGQGgA AAADAwEGQGgAAAADAwEGQGgAAAADAwEGQGgAAAADAwEGQGgAAAADAwEGACgA AAADBAgAKAAAAAMCBkAoAAAAAwQGQGgAAAADAwEGQGgAAAADAwEGQCgAAAAD BAZAaAAAAAMDAQZAaAAAAAMDAQcAaAAAAAMCAQYAYAAAAAICBwAoAAAAAwMG ACgAAAADBAgAKAAAAAMCBgAoAAAAAwQGAGgAAAADAwEGQCgAAAADBAZAaAAA AAMDAQZAaAAAAAMDAQZAKAAAAAMEBkBoAAAAAwMBBkBoAAAAAwMBEQAgAAAA ARAAIAAAAAIGACgAAAADBBAAKAAAAAMCCwABAAECAAIDAAMEAAQFAAUGIAYH aAwHCGgMCAloDAkKaAwKC2gMAgwgDA0oAgwOIA4PaAwPEGgMEBFoDBESaAwS E2gMERQgFBUAFRYAFhcgFxgoAhcZIBkaKAIaGyAbHGgMHB1oDB0eaAweH2gM HyBoDB4hABkiACIjACMkKAIFAAALBmgMEw5oDCMWICAbaAxCBQAAAAYABQQD AgEGBwgJCgsGBg8QERITDgUXFiMiGQYcHR4fIBsXBAAAAAAAAAAW </structure-pickle> <structure-indexed-at type="dateTime">2026-09-19T05:46:23Z</structure-indexed-at> </compound>